There is a need to understand the predictors of prostatic urethral lift (PUL) durability to help physicians counsel patients and optimize outcomes. A simple logistic regression analysis was performed ...
A head-to-head trial of minimally invasive procedures to manage benign prostatic hyperplasia found that urethral implants appear to provide more durable control of symptoms than thermal therapy. The ...
Surgical treatments for lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO) are affected by potentially bothersome side effects on sexual, and, above all, ejaculatory ...
WASHINGTON -- Implantation of a temporary prostatic urethra expander resulted in sustained improvements of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), results ...
Frequent urination, urgency and waking up at night to urinate are often blamed on an enlarged prostate. However, doctors say ...
Taken together, long-term data from a pivotal sham-controlled trial and a single-arm study demonstrate Optilume BPH’s durable efficacy over at least 3 years. The Optilume® benign prostatic hyperplasia ...
Interim results from the pivotal trial validate Urocross Expander for sustained BPH symptom improvement after implant retrieval. The Urocross Expander System improves lower urinary tract symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results